DBV Technologies submits BLA to FDA for VIASKIN Peanut Patch in children aged 4-7

DBV Technologies announced it has submitted a Biologics License Application to the U.S. FDA for its VIASKIN Peanut Patch for the treatment of peanut allergy in children aged 4 to 7 years.

Detected & updated continuously · Source: Nebula